187 related articles for article (PubMed ID: 27619225)
1. Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months.
Vold SD; Voskanyan L; Tetz M; Auffarth G; Masood I; Au L; Ahmed II; Saheb H
Ophthalmol Ther; 2016 Dec; 5(2):161-172. PubMed ID: 27619225
[TBL] [Abstract][Full Text] [Related]
2. Five-Year, Prospective, Randomized, Multi-Surgeon Trial of Two Trabecular Bypass Stents versus Prostaglandin for Newly Diagnosed Open-Angle Glaucoma.
Fechtner RD; Voskanyan L; Vold SD; Tetz M; Auffarth G; Masood I; Au L; Khouri AS; Ahmed IIK; Saheb H
Ophthalmol Glaucoma; 2019; 2(3):156-166. PubMed ID: 32672584
[TBL] [Abstract][Full Text] [Related]
3. Prospective Evaluation of Two iStent
Myers JS; Masood I; Hornbeak DM; Belda JI; Auffarth G; Jünemann A; Giamporcaro JE; Martinez-de-la-Casa JM; Ahmed IIK; Voskanyan L; Katz LJ
Adv Ther; 2018 Mar; 35(3):395-407. PubMed ID: 29476443
[TBL] [Abstract][Full Text] [Related]
4. Implantation of two second-generation trabecular micro-bypass stents and topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 18-month follow-up.
Berdahl J; Voskanyan L; Myers JS; Hornbeak DM; Giamporcaro JE; Katz LJ; Samuelson TW
Clin Exp Ophthalmol; 2017 Nov; 45(8):797-802. PubMed ID: 28384377
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up.
Chang DF; Donnenfeld ED; Katz LJ; Voskanyan L; Ahmed II; Samuelson TW; Giamporcaro JE; Hornbeak DM; Solomon KD
Clin Ophthalmol; 2017; 11():523-528. PubMed ID: 28352151
[TBL] [Abstract][Full Text] [Related]
6. Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study.
Hengerer FH; Auffarth GU; Riffel C; Conrad-Hengerer I
Adv Ther; 2019 Jul; 36(7):1606-1617. PubMed ID: 31119690
[TBL] [Abstract][Full Text] [Related]
7. iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes.
Berdahl J; Voskanyan L; Myers JS; Katz LJ; Samuelson TW
Clin Exp Ophthalmol; 2020 Aug; 48(6):767-774. PubMed ID: 32311201
[TBL] [Abstract][Full Text] [Related]
8. Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up.
Lindstrom R; Lewis R; Hornbeak DM; Voskanyan L; Giamporcaro JE; Hovanesian J; Sarkisian S
Adv Ther; 2016 Nov; 33(11):2082-2090. PubMed ID: 27739003
[TBL] [Abstract][Full Text] [Related]
9. Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma.
Hengerer FH; Auffarth GU; Riffel C; Conrad-Hengerer I
Ophthalmol Ther; 2018 Dec; 7(2):405-415. PubMed ID: 30430427
[TBL] [Abstract][Full Text] [Related]
10. Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes.
Katz LJ; Erb C; Carceller Guillamet A; Fea AM; Voskanyan L; Giamporcaro JE; Hornbeak DM
Clin Ophthalmol; 2018; 12():255-262. PubMed ID: 29440867
[TBL] [Abstract][Full Text] [Related]
11. Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
Samuelson TW; Sarkisian SR; Lubeck DM; Stiles MC; Duh YJ; Romo EA; Giamporcaro JE; Hornbeak DM; Katz LJ;
Ophthalmology; 2019 Jun; 126(6):811-821. PubMed ID: 30880108
[TBL] [Abstract][Full Text] [Related]
12. Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication.
Katz LJ; Erb C; Carceller GA; Fea AM; Voskanyan L; Wells JM; Giamporcaro JE
Clin Ophthalmol; 2015; 9():2313-20. PubMed ID: 26715834
[TBL] [Abstract][Full Text] [Related]
13. Four-Year Outcomes of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication.
Lindstrom R; Sarkisian SR; Lewis R; Hovanesian J; Voskanyan L
Clin Ophthalmol; 2020; 14():71-80. PubMed ID: 32021070
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results.
Salimi A; Watt H; Harasymowycz P
Eye Vis (Lond); 2021 Nov; 8(1):43. PubMed ID: 34782017
[TBL] [Abstract][Full Text] [Related]
15. One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities.
Salimi A; Lapointe J; Harasymowycz P
Ophthalmol Ther; 2019 Dec; 8(4):563-575. PubMed ID: 31538316
[TBL] [Abstract][Full Text] [Related]
16. Trabecular micro-bypass stent implantation during small-incision cataract surgery for open-angle glaucoma or ocular hypertension: Long-term results.
Neuhann TH
J Cataract Refract Surg; 2015 Dec; 41(12):2664-71. PubMed ID: 26796447
[TBL] [Abstract][Full Text] [Related]
17. A prospective 3-year follow-up trial of implantation of two trabecular microbypass stents in open-angle glaucoma.
Donnenfeld ED; Solomon KD; Voskanyan L; Chang DF; Samuelson TW; Ahmed II; Katz LJ
Clin Ophthalmol; 2015; 9():2057-65. PubMed ID: 26604675
[TBL] [Abstract][Full Text] [Related]
18. Three-year outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic population with primary open-angle glaucoma.
Gallardo MJ; Supnet RA
Clin Ophthalmol; 2019; 13():869-879. PubMed ID: 31239633
[No Abstract] [Full Text] [Related]
19. iStent Trabecular Micro-Bypass Stent Implantation with Cataract Surgery in a Japanese Glaucoma Population.
Nitta K; Yamada Y; Morokado S; Sugiyama K
Clin Ophthalmol; 2020; 14():3381-3391. PubMed ID: 33116389
[TBL] [Abstract][Full Text] [Related]
20. [Results of argon laser treatment of 100 eyes with open-angle glaucoma (trabeculoplasty, trabeculoretraction)].
Moulin F; Haut J
J Fr Ophtalmol; 1983; 6(8-9):661-70. PubMed ID: 6687151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
